Who
Jitendra Wadhane
Prin Fin & Acct Officer
Company insider
Files Form 4 as: Prin Fin & Acct Officer, Pyxis Oncology.
In numbers
- Trades disclosed
- 16
- Buys
- 3
- Sells
- 0
- Bought
- $18K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 24 Mar 2023
- Last trade
- 24 Mar 2026
- Last filed
- 25 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Mar 2026filed 25 Mar 2026 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Code A | —109,461 at $0.00 | filing |
| 24 Mar 2026filed 25 Mar 2026 | PYXS Pyxis Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —262,635 at $0.00 | filing |
| 24 Mar 2026filed 25 Mar 2026 | PYXS Pyxis Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —262,635 at $0.00 | filing |
| 24 Mar 2026filed 25 Mar 2026 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Code A | —109,461 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | PYXS Pyxis Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $259K263,782 at $0.98 | filing |
| 23 Dec 2024filed 23 Dec 2024 | PYXS Pyxis Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 26 Mar 2024filed 28 Mar 2024 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Code A | —131,484 at $0.00 | filing |
| 15 Nov 2023filed 17 Nov 2023 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 27 Sep 2023filed 27 Sep 2023 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Bought | $4,6752,500 at $1.87 | filing |
| 25 Sep 2023filed 25 Sep 2023 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Bought | $8,8505,000 at $1.77 | filing |
| 22 Sep 2023filed 22 Sep 2023 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Bought | $4,3502,500 at $1.74 | filing |
| 7 Sep 2023filed 8 Sep 2023 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Code A | —93,896 at $0.00 | filing |
| 24 Mar 2023filed 28 Mar 2023 | PYXS Pyxis Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code D | —157,257 | filing |
| 24 Mar 2023filed 28 Mar 2023 | PYXS Pyxis Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —157,257 | filing |
| 24 Mar 2023filed 28 Mar 2023 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Code A | —29,393 at $0.00 | filing |
| 24 Mar 2023filed 28 Mar 2023 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.